Improving Quality of Life in Lung Cancer Patients Using Preference-Based Electronic Monitoring and Linked Clinical Data A Randomized Trial
Led by University of Bayreuth · Updated on 2024-12-16
220
Participants Needed
8
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether a preference-oriented quality of life QoL monitoring system with specific diagnostic and therapeutic options can improve the well-being of patients with lung cancer during routine follow-up care. This study builds on successful QoL interventions for breast and colorectal cancer and aims to adapt the system for lung cancer patients in multiple centers. The study uses electronic QoL questionnaires and links patient data with a cancer registry to support analysis.
Participants are randomly assigned to one of two groups. The intervention group receives real-time results from an electronic QoL monitoring system based on the EORTC QLQ-C30 and QLQ-LC29 questionnaires, along with access to a multiprofessional network of therapists such as pain therapy, psychotherapy, social support, nutrition counseling, physiotherapy, fitness, respiratory therapy, and palliative care. The control group also completes QoL assessments but neither patients nor their physicians receive the results however, the therapist network is available for both groups. QoL is assessed at study entry and monthly for six months.
Throughout the six-month follow-up, participants complete QoL questionnaires at baseline and monthly intervals. Researchers monitor the proportion of patients needing QoL therapy based on a profile with eight dimensions, with a focus on whether the intervention reduces this need after six months. Data collection includes linking clinical information from a cancer registry. The study involves multiple assessments, therapeutic referrals, and ongoing monitoring to evaluate quality of life improvements in lung cancer patients.
CONDITIONS
Brief Title
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Research Team
M
Martin Emmert, PhD, Prof.
M
Monika Klinkhammer-Schalke, MD, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Primary diagnosis of lung cancer (ICD C33/C34, all stages)
Treatment at one of six specified hospitals
Diagnosis date within 2 months before study entry
Provided informed consent
You will not qualify if you...
No available study clinician for recruitment
Misclassification of diagnosis (no lung tumor)
Refusal by coordinating practitioner to participate
Residence outside defined study region in Bavaria, Germany
Under 18 years of age
Pregnancy or breastfeeding
Unable to complete quality of life questionnaires due to physical, psychological, cognitive, or language reasons
Patient refuses participation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 6 months
Participants receive quality of life (QoL) assessments using electronic questionnaires at study entry and monthly for 6 months. In the intervention group, participants and their physicians receive real-time results and access to a network of therapists for addressing QoL deficits. In the control group, QoL is also assessed but results are not shared with participants or physicians.
7 visits (1 at study entry and 6 monthly follow-ups)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing 3-Needle and 5-Needle Genicular Nerve Blocks for Pain and Quality of Life in Knee Osteoarthritis
Using 3-D Virtual Lung Resection to Predict Lung Function After VATS Surgery for Non-Small Cell Lung Cancer
Developing Advanced 4D-MRI Imaging to Improve Radiation Therapy for Lung and Liver Cancer
Including Healthy Adult Volunteers for Imaging Research
Exploratory Study of 68Ga-SorB PETCT Imaging to Diagnose Sortilin-Positive Solid Tumors
A Clinical and Biological Database Study of Lung Cancer Patients Receiving Standard Treatments
Study on Causes and Impact of Vulnerability in Adult Men With Serious Diseases Including Cancer and Fractures
Community Health Approaches to Increase Lung Cancer Screening and Tobacco Treatment in Community Health Centers
Community-Based Digital and Behavioral Management for Nocturia in Older Adults
Feasibility Study of MRI-Guided Stereotactic Ablative Radiotherapy for Abdominal and Lung Tumors
Phase 12 Study of 3H-10000 Infusion for Adults with Unresectable or Metastatic Lung or Stomach Cancer
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Preference-oriented quality of life monitoring and linkage with clinical registry data: study protocol of a randomised clinical trial in patients with lung cancer (LePaLuMo Study).
Patricia Lindberg-Scharf, Martin Emmert, Michael Koller...
Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer.
Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.
Monika Klinkhammer-Schalke, Brunhilde Steinger, Michael Koller...
Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care.
Patricia Lindberg-Scharf, Brunhilde Steinger, Michael Koller...